RARE-X is a nonprofit platform that collects, structures, and shares patient data for rare diseases to speed diagnosis and therapeutic research. By partnering with patient advocacy groups, it offers symptom‑based data collection, dynamic consent, and robust governance, delivering high‑quality, open‑science datasets that researchers and sponsors can access to accelerate drug development.
Funding
Funding not disclosed
Founders
Product
Problem
Rare disease patients and researchers face fragmented, low‑quality data that is difficult to collect, standardize, and share across borders, slowing diagnosis and therapeutic development for the majority of over 10,000 conditions.
Solution
RARE‑X is a nonprofit, open‑science platform that partners with patient advocacy groups to capture symptom‑based patient‑reported outcomes, molecular information, and study data at scale. The platform structures this information using standardized clinical outcome assessments selected by expert working groups that include clinicians, researchers, and patients. Dynamic consent lets participants modify their data‑sharing preferences, while robust international governance ensures compliance with privacy regulations. Structured datasets are made available through an open data repository, enabling researchers, clinicians, and sponsors to conduct cross‑disorder analyses and accelerate the development of diagnostics and therapies. Ongoing patient‑engagement services help maintain long‑term participation and data quality.
Target Audience
Primary users are patient advocacy organizations, academic researchers, clinicians, and pharmaceutical sponsors seeking high‑quality, interoperable rare‑disease data to inform diagnostics and drug development.
Features
- Symptom‑driven data capture that supports comprehensive disease characterization and cross‑disorder research
- Expert working groups define and curate clinical outcome assessments aligned with patient priorities
- Dynamic consent framework allowing participants to update sharing preferences in real time
- Internationally compliant data governance ensuring secure, privacy‑preserving collection and sharing
- Structured data repository delivering PRO, molecular, and study data in standardized formats
- Open‑science platform that provides unrestricted access to high‑quality datasets for academic and industry researchers
- Full‑service patient engagement and program management to sustain long‑term community involvement